BAXTER INTERNATIONAL INC (BAX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BAX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BAX | Former Senior Vice President of Strategy and Business Development, Covidien plc; Independent Director | 65 | ["Extensive experience in business development and strategy in the healthcare industry, including significant mergers & acquisitions and integration experience", "Expertise in portfolio management and resource allocation decision making", "Former Senior Vice President of Strategy and Business Development at Covidien plc", "Senior Advisor for the Healthcare Investment Banking Practice at Perella Weinberg Partners L.P.", "Significant experience in financial valuation, resource allocation and portfolio optimization", "Extensive experience in research and development operations", "Deep expertise in mergers and acquisitions, divestitures, strategic transitions and identifying new market opportunities", "International executive experience in global healthcare and medical device companies", "Healthcare Marketing / Delivery", "Quality, Regulatory and Compliance", "Other Sector Leadership"] | ["Compensation and Human Capital", "Quality and Regulatory Compliance", "Quality and Regulatory Compliance Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SOLV | Former SVP, Strategy and Business Development and Licensing, Covidien Inc.; Director | 65 | ["Former SVP, Strategy and Business Development and Licensing, Covidien Inc.", "Over 30 years of experience in strategic leadership roles and member of multiple boards at healthcare and medical device companies", "Deep knowledge through executive and board experience of financial valuation and portfolio optimization", "Service on the boards and in senior strategy roles at global healthcare and medical device companies", "Extensive and thorough experience in guiding companies undergoing significant transitions, including M&A, as well as portfolio management and spin-offs", "Considerable experience overseeing acquisition and portfolio management of science and research companies", "Strategic responsibility for large multinational companies operating in regulated industries; Roles in product development and licensing and distribution", "Oversight in multiple roles of revenue growth and margin enhancement for large global companies", "Significant experience with mergers and acquisitions as well as divestitures for multiple public and private companies with oversight over strategic risk", "Leadership of large teams particularly in performance and advancement; Roles on public company boards with oversight over human capital management"] | ["GC", "STQC", "Governance", "Science, Technology and Quality"] | 2026 |
Biography sourced from the proxy statement filing.
Amy A. Wendell | 65 Independent Director Former Senior Vice President of Strategy and Business Development Covidien plc Director Since 2019 Independent Yes Board Committees Compensation and Human Capital; Quality and Regulatory Compliance Current Other Public Company Directorships Axogen Inc. Hologic, Inc. Solventum Corporation Prior Company Directorships (within past five years) N/A Professional Experience Perella Weinberg Partners L.P. , a global financial services firm Senior Advisor for the Healthcare Investment Banking Practice (2016 to 2019) McKinsey & Company , a management consulting firm Senior Advisor for the Strategy and Corporate Finance Practice (2015 to 2018) Transactions Advisory Board member (2015 to 2018) Covidien plc , a global healthcare company and manufacturer of medical devices and supplies Senior Vice President of Strategy and Business Development and Licensing (2006 to 2015) From 1986 to 2015, held roles of increasing responsibility (including at its predecessors Tyco International plc and Kendall Healthcare Products Company) from engineering to product management and business development. Skills and Experiences Supporting Nomination Healthcare Marketing / Delivery - Over 30 years of experience serving in various strategic leadership roles in the healthcare industry, including service as a senior advisor for Parella Weinberg Partners L.P.'s (Perella) Healthcare Investment Banking Practice and in numerous roles of increasing responsibility at Covidien plc (Covidien), including Senior Vice President of Strategy and Business Development and Licensing. Also serves as a member of multiple boards at healthcare and medical device companies, including Axogen Inc. (Axogen), Hologic Inc. (Hologic) and Solventum Corporation (Solventum). Quality and Regulatory Compliance - Gained meaningful experience while serving in various roles of increasing responsibility at Covidien, including in roles with product development and licensing and distribution responsibilities and oversight. Serves on the Baxter's Quality and Regulatory Compliance Committee and Solventum's Science, Technology and Quality Committee. Financial Expertise / Risk Management - Significant experience in financial valuation, resource allocation and portfolio optimization through senior advisor roles at Parella and McKinsey & Company (McKinsey). Serves on Axogen's Audit Committee. Manufacturing and R&D - Obtained extensive experience in research and development operations while serving in various roles at Covidien, including as Senior Vice President of Strategy and Business Development and Licensing and other roles where she had product development and engineering oversight responsibilities. M&A / Transactional - Deep expertise in mergers and acquisitions, divestitures, strategic transitions and identifying new market opportunities. As Senior Vice President of Strategy and Business Development and Licensing at Covidien, she managed all business development, including acquisitions, equity investments, divestitures and licensing and distribution, and led Covidien s strategy and portfolio management initiatives. She has also guided multiple public and private companies undergoing significant transitions in her senior advisor roles at Parella and McKinsey. Provided oversight support as a member of Baxter's former Operating Committee. International - Served as an executive at Senior Vice President of Strategy and Business Development and Licensing at Covidien and in senior strategy roles at global healthcare and medical device companies. She also serves on the boards of directors of global companies, including Axogen, Hologic and Solventum. Other Sector Leadership - Served in a senior advisory role to public and private companies outside of the medical technologies space at McKinsey.